Winner Medical Co., Ltd. (SHE:300888)
China
· Delayed Price · Currency is CNY 39.02
+0.32 (0.83%)
At close: Dec 5, 2025
Winner Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 10,724 | 8,896 | 8,124 | 11,258 | 7,976 | 12,438 | Upgrade
|
| Other Revenue | 81.38 | 81.38 | 60.7 | 93.58 | 61.2 | 96.17 | Upgrade
|
| Revenue | 10,805 | 8,978 | 8,185 | 11,351 | 8,037 | 12,534 | Upgrade
|
| Revenue Growth (YoY) | 31.05% | 9.69% | -27.89% | 41.23% | -35.88% | 173.99% | Upgrade
|
| Cost of Revenue | 5,813 | 4,880 | 4,393 | 6,340 | 4,121 | 5,212 | Upgrade
|
| Gross Profit | 4,992 | 4,098 | 3,792 | 5,011 | 3,916 | 7,322 | Upgrade
|
| Selling, General & Admin | 3,415 | 2,931 | 2,756 | 2,649 | 2,444 | 2,012 | Upgrade
|
| Research & Development | 407.63 | 348.16 | 322.05 | 487.58 | 298.16 | 411.38 | Upgrade
|
| Other Operating Expenses | 60.97 | 26.19 | 39.96 | 98.09 | 65.39 | 116.57 | Upgrade
|
| Operating Expenses | 3,895 | 3,307 | 3,115 | 3,229 | 2,804 | 2,563 | Upgrade
|
| Operating Income | 1,097 | 790.82 | 677.12 | 1,782 | 1,113 | 4,759 | Upgrade
|
| Interest Expense | -71.58 | -54.86 | -63.44 | -50.04 | -29.99 | -3.61 | Upgrade
|
| Interest & Investment Income | 143.07 | 192.48 | 261.26 | 175.38 | 240.42 | 44.93 | Upgrade
|
| Currency Exchange Gain (Loss) | 40.19 | 40.19 | -7.63 | 52.07 | 0.61 | -239.43 | Upgrade
|
| Other Non Operating Income (Expenses) | -12.69 | -1.2 | 0.68 | -72.25 | -4.27 | -12.37 | Upgrade
|
| EBT Excluding Unusual Items | 1,196 | 967.44 | 867.99 | 1,887 | 1,319 | 4,549 | Upgrade
|
| Impairment of Goodwill | -90.74 | -90.74 | -188.79 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -6.71 | 2.86 | 46.68 | 32.15 | 58.47 | 11.18 | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.92 | 5.88 | 32.2 | 3.73 | 3.25 | 0.01 | Upgrade
|
| Asset Writedown | -0.93 | -16.45 | -93.43 | -74.78 | -20.26 | -124.55 | Upgrade
|
| Other Unusual Items | 75.76 | 39.37 | 85.19 | 71.05 | 101.8 | 66.94 | Upgrade
|
| Pretax Income | 1,176 | 908.35 | 749.85 | 1,920 | 1,463 | 4,502 | Upgrade
|
| Income Tax Expense | 247.01 | 167.64 | 121.3 | 245.17 | 225.32 | 679.91 | Upgrade
|
| Earnings From Continuing Operations | 929.34 | 740.71 | 628.55 | 1,674 | 1,237 | 3,823 | Upgrade
|
| Minority Interest in Earnings | -55.03 | -45.33 | -48.14 | -23.62 | 1.88 | -12.14 | Upgrade
|
| Net Income | 874.31 | 695.38 | 580.4 | 1,651 | 1,239 | 3,810 | Upgrade
|
| Net Income to Common | 874.31 | 695.38 | 580.4 | 1,651 | 1,239 | 3,810 | Upgrade
|
| Net Income Growth | - | 19.81% | -64.84% | 33.20% | -67.47% | 597.50% | Upgrade
|
| Shares Outstanding (Basic) | 583 | 584 | 592 | 592 | 596 | 544 | Upgrade
|
| Shares Outstanding (Diluted) | 583 | 584 | 592 | 592 | 596 | 545 | Upgrade
|
| Shares Change (YoY) | -0.69% | -1.33% | 0.10% | -0.77% | 9.42% | 3.31% | Upgrade
|
| EPS (Basic) | 1.50 | 1.19 | 0.98 | 2.79 | 2.08 | 7.00 | Upgrade
|
| EPS (Diluted) | 1.50 | 1.19 | 0.98 | 2.79 | 2.08 | 6.99 | Upgrade
|
| EPS Growth | - | 21.43% | -64.88% | 34.23% | -70.28% | 575.19% | Upgrade
|
| Free Cash Flow | 748.83 | 364.87 | 310.26 | 1,784 | 128.42 | 4,194 | Upgrade
|
| Free Cash Flow Per Share | 1.28 | 0.62 | 0.52 | 3.02 | 0.21 | 7.70 | Upgrade
|
| Dividend Per Share | 0.700 | 0.650 | 0.500 | 1.357 | 0.900 | 1.800 | Upgrade
|
| Dividend Growth | -22.22% | 30.00% | -63.16% | 50.79% | -50.00% | - | Upgrade
|
| Gross Margin | 46.20% | 45.65% | 46.33% | 44.15% | 48.73% | 58.42% | Upgrade
|
| Operating Margin | 10.15% | 8.81% | 8.27% | 15.70% | 13.84% | 37.97% | Upgrade
|
| Profit Margin | 8.09% | 7.75% | 7.09% | 14.54% | 15.42% | 30.40% | Upgrade
|
| Free Cash Flow Margin | 6.93% | 4.06% | 3.79% | 15.72% | 1.60% | 33.46% | Upgrade
|
| EBITDA | 1,472 | 1,141 | 992.8 | 2,049 | 1,279 | 4,918 | Upgrade
|
| EBITDA Margin | 13.63% | 12.71% | 12.13% | 18.05% | 15.92% | 39.24% | Upgrade
|
| D&A For EBITDA | 375.41 | 349.81 | 315.68 | 266.49 | 166.69 | 158.62 | Upgrade
|
| EBIT | 1,097 | 790.82 | 677.12 | 1,782 | 1,113 | 4,759 | Upgrade
|
| EBIT Margin | 10.15% | 8.81% | 8.27% | 15.70% | 13.84% | 37.97% | Upgrade
|
| Effective Tax Rate | 21.00% | 18.46% | 16.18% | 12.77% | 15.40% | 15.10% | Upgrade
|
| Revenue as Reported | 10,805 | 8,978 | 8,185 | 11,351 | 8,037 | 12,534 | Upgrade
|
| Advertising Expenses | - | 816.38 | 651.82 | 600.16 | 692.45 | 372.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.